Good Pharmacy Practice
The International Pharmaceutical Federation (FIP) first adopted the guidelines for Good Pharmaceutical Practice in 1993. These guidelines were developed as a reference to be used by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards of Good Pharmacy Practice.
A revised version of this document was endorsed by WHO in 1997 and subsequently approved by the FIP Council in 1997.
In 2011, FIP and WHO adopted an updated version of Good Pharmacy Practice entitled "Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services".
Full reference: Joint FIP/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, No. 961, 2011. Geneva: World Health Organization, 2011.
In this document, the aim of pharmacy practice aim is defined as to "contribute to health improvement and to help patients with health problems to make the best use of their medicines."
GPP is defined as "the practice of pharmacy that responds to the needs of the people who use the pharmacists’ services to provide optimal, evidence-based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines."
The 2011 GPP document underlines the requirements of Good Pharmacy Practice and how to set standards required for GPP, (which also imply a quality management framework and a strategic plan for developing services).
GPP are organised around 4 major roles for pharmacists
- Role 1: Prepare, obtain, store, secure, distribute, administer, dispense and dispose of medical products
- Role 2: Provide effective medication therapy management
- Role 3: Maintain and improve professional performance
- Role 4: Contribute to improve effectiveness of the health-care system and public health
Each function is structured in several roles, and for each role, a list of minimum national standards to be established have been set.
WHO/FIP GPP should serve as a guidance document for the development of specific standards of GPP at national levels by national pharmacists associations and other related stakeholders.
When establishing minimum standards on GPP, it is important to define the roles played by pharmacists, as expected
by patients and society. Secondly, relevant functions for which pharmacists have direct responsibility and accountability need to be determined within each role. Thirdly, minimum national standards should then be established, based upon the need to demonstrate competency in a set of activities supporting each function and role.
To access to the 2011 document, click here
Developing Pharmacy Practice
In addition to the FIP involvement in Good Pharmacy Practice through these Guidelines, FIP together with WHO has published a joint handbook entitled "Developing pharmacy practice - A focus on patient care".
This handbook sets out a the new paradigm for pharmacy practice. Its aim is to
guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge, has been written in response to a need to define, develop and generate global understanding of pharmaceutical care at all levels.
Click here to download the English version: "Developing pharmacy practice - A focus on patient care"
Click here to download the French version: "Élargir la pratique pharmaceutique - Recentrer les soins sur les patients"
Click here to download the Spanish version: "Desarrollo de la práctica de farmacia - Centrada en la atención del paciente"
Click here to download the Russian version: "Развитие фармацевтической практики: фокус на пациента"
Click here to download the Chinese version: "开展药学实践 以患者为中心"